Even before becoming the stars of Nathan Fielder and Lance Oppenheim’s much-buzzed-about new documentary, Elizabeth Holmes and Billy Evans were a special kind of couple. Holmes “may have ultimately failed to change the world in the way she set out,” Evans wrote in a letter at the time of Holmes’ sentencing in 2022, “but she has undeniably changed mine.” The Theranos founder, in the hardest years of her life, taught her husband “a patience” that he “would have previously dismissed as unnecessary and soft.”

She brought out his inner light, another sentencing letter from a friend of the couple reports: When they returned from a “monthslong camping trip,” Evans “displayed a new level of compassion in his demeanor, a strong sense of intention with his actions, and a heightened desire to listen to and look at others with purpose.” Whatever others might think, Evans was saying, Holmes wasn’t the only one of the pair that had been given a second chance. And they might get a second second chance with Haemanthus, a company that Evans is keen to reassure social media followers is absolutely—most definitely— “not Theranos 2.0.” A person familiar with the business told The Wall Street Journal that Holmes is not involved.

0. They discuss the trajectory to make a working prototype of something on camera; they talk about collaborating on product ideas from prison. “To meet her, to spend time with her, that was the intention of the film,” the Austin, Texas-based Evans told David Friedberg, a cohost of the podcast All-In .

Source link